Al-Othman R, Al-Jarallah A, Babiker F
Front Pharmacol. 2024; 15:1398630.
PMID: 39611167
PMC: 11603114.
DOI: 10.3389/fphar.2024.1398630.
Pedzinska-Betiuk A, Gergs U, Weresa J, Remiszewski P, Harasim-Symbor E, Malinowska B
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39459019
PMC: 11509923.
DOI: 10.3390/ph17101379.
Al-Jarallah A, Babiker F
Pharmaceutics. 2024; 16(4).
PMID: 38675158
PMC: 11054943.
DOI: 10.3390/pharmaceutics16040497.
Takahashi K, Yoshikawa Y, Kanda M, Hirata N, Yamakage M
J Anesth. 2023; 37(6):961-970.
PMID: 37750978
DOI: 10.1007/s00540-023-03261-w.
Farkasova F, Kindernay L, Ferko M, Rajtik T, Szobi A, Ravingerova T
Physiol Res. 2023; 72(S1):S11-S22.
PMID: 37294114
PMC: 10292815.
DOI: 10.33549/physiolres.935019.
The RISK pathway leading to mitochondria and cardioprotection: how everything started.
Yellon D, Beikoghli Kalkhoran S, Davidson S
Basic Res Cardiol. 2023; 118(1):22.
PMID: 37233787
PMC: 10220132.
DOI: 10.1007/s00395-023-00992-5.
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
Ferdinandy P, Andreadou I, Baxter G, Botker H, Davidson S, Dobrev D
Pharmacol Rev. 2023; 75(1):159-216.
PMID: 36753049
PMC: 9832381.
DOI: 10.1124/pharmrev.121.000348.
High Density Lipoprotein Reduces Blood Pressure and Protects Spontaneously Hypertensive Rats Against Myocardial Ischemia-Reperfusion Injury in an SR-BI Dependent Manner.
Al-Jarallah A, Babiker F
Front Cardiovasc Med. 2022; 9:825310.
PMID: 35387446
PMC: 8977778.
DOI: 10.3389/fcvm.2022.825310.
Increased Endogenous Activity of the Renin-Angiotensin System Reduces Infarct Size in the Rats with Early Angiotensin II-dependent Hypertension which Survive the Acute Ischemia/Reperfusion Injury.
Huskova Z, Kikerlova S, Sadowski J, Alanova P, Sedlakova L, Papousek F
Front Pharmacol. 2021; 12:679060.
PMID: 34122103
PMC: 8193500.
DOI: 10.3389/fphar.2021.679060.
Ischaemic post-conditioning in rats: Responder and non-responder differ in transcriptome of mitochondrial proteins.
Schreckenberg R, Klein J, Kutsche H, Schulz R, Gomori K, Bencsik P
J Cell Mol Med. 2020; 24(10):5528-5541.
PMID: 32297702
PMC: 7214154.
DOI: 10.1111/jcmm.15209.
Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection.
Billah M, Ridiandries A, Allahwala U, Mudaliar H, Dona A, Hunyor S
Oncotarget. 2019; 10(2):216-244.
PMID: 30719216
PMC: 6349428.
DOI: 10.18632/oncotarget.26537.
An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning.
Hentia C, Rizzato A, Camporesi E, Yang Z, Muntean D, Sandesc D
Brain Behav. 2018; 8(5):e00959.
PMID: 29761012
PMC: 5943756.
DOI: 10.1002/brb3.959.
Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension.
Cervenka L, Huskova Z, Kopkan L, Kikerlova S, Sedlakova L, Vanourkova Z
J Hypertens. 2018; 36(6):1326-1341.
PMID: 29570510
PMC: 7375140.
DOI: 10.1097/HJH.0000000000001708.
Application of ischemic postconditioning's algorithms in tissues protection: response to methodological gaps in preclinical and clinical studies.
Feyzizadeh S, Badalzadeh R
J Cell Mol Med. 2017; 21(10):2257-2267.
PMID: 28402080
PMC: 5618671.
DOI: 10.1111/jcmm.13159.
Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration.
Epps J, Smart N
Cardiovasc Diabetol. 2016; 15(1):130.
PMID: 27613524
PMC: 5018170.
DOI: 10.1186/s12933-016-0444-z.
Short-and long-term effects of ischemic postconditioning in STEMI patients: a meta-analysis.
Gao J, Luo J, Liu F, Zheng Y, Chen B, Chen Q
Lipids Health Dis. 2015; 14:147.
PMID: 26573572
PMC: 4647593.
DOI: 10.1186/s12944-015-0151-x.
The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.
McCafferty K, Forbes S, Thiemermann C, Yaqoob M
Dis Model Mech. 2014; 7(12):1321-33.
PMID: 25481012
PMC: 4257001.
DOI: 10.1242/dmm.016741.
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies.
Lecour S, Botker H, Condorelli G, Davidson S, Garcia-Dorado D, Engel F
Cardiovasc Res. 2014; 104(3):399-411.
PMID: 25344369
PMC: 4242141.
DOI: 10.1093/cvr/cvu225.
Anaesthetic Postconditioning at the Initiation of CPR Improves Myocardial and Mitochondrial Function in a Pig Model of Prolonged Untreated Ventricular Fibrillation.
Riess M, Matsuura T, Bartos J, Bienengraeber M, Aldakkak M, McKnite S
Resuscitation. 2014; 85(12):1745-51.
PMID: 25281906
PMC: 4276313.
DOI: 10.1016/j.resuscitation.2014.09.019.
Catestatin increases the expression of anti-apoptotic and pro-angiogenetic factors in the post-ischemic hypertrophied heart of SHR.
Penna C, Pasqua T, Amelio D, Perrelli M, Angotti C, Tullio F
PLoS One. 2014; 9(8):e102536.
PMID: 25099124
PMC: 4123866.
DOI: 10.1371/journal.pone.0102536.